A 58-year-old patient with asthma presents with moderate shortness of breath. Which is the first medication the paramedic should administer?

A 58-year-old patient with asthma presents with moderate shortness of breath. Which is the first medication the paramedic should administer?

• A. Epinephrine 1:1000 SQ/IM
• B. Albuterol via nebulizer
• C. Epinephrine 1:10,000 IVP
• D. Benadryl IM

Answer: (B)

The main idea is that in an acute asthma flare with moderate shortness of breath, the immediate priority is to rapidly relieve bronchospasm with a fast-acting inhaled bronchodilator. Albuterol given by nebulizer delivers a high concentration of medication directly to the airways, quickly relaxing the bronchial smooth muscle through stimulation of beta-2 receptors. This targeted approach improves ventilation within minutes and reduces work of breathing, making it the most effective first intervention in this scenario. Systemic options like epinephrine, whether IM or IV, carry broader effects on heart rate and vascular tone and are generally reserved for more severe situations such as anaphylaxis or life-threatening bronchospasm unresponsive to inhaled therapy. An antihistamine like Benadryl does not address the bronchoconstriction driving asthma symptoms and won’t provide meaningful rapid relief. So, starting with inhaled albuterol via nebulizer maximizes rapid airway relief with the fewest systemic side effects, aligning with how paramedics manage a moderate acute asthma attack. If needed, therapy can be escalated with additional treatments or adjuncts depending on the patient’s response and vital signs.

The main idea is that in an acute asthma flare with moderate shortness of breath, the immediate priority is to rapidly relieve bronchospasm with a fast-acting inhaled bronchodilator. Albuterol given by nebulizer delivers a high concentration of medication directly to the airways, quickly relaxing the bronchial smooth muscle through stimulation of beta-2 receptors. This targeted approach improves ventilation within minutes and reduces work of breathing, making it the most effective first intervention in this scenario.

Systemic options like epinephrine, whether IM or IV, carry broader effects on heart rate and vascular tone and are generally reserved for more severe situations such as anaphylaxis or life-threatening bronchospasm unresponsive to inhaled therapy. An antihistamine like Benadryl does not address the bronchoconstriction driving asthma symptoms and won’t provide meaningful rapid relief.

So, starting with inhaled albuterol via nebulizer maximizes rapid airway relief with the fewest systemic side effects, aligning with how paramedics manage a moderate acute asthma attack. If needed, therapy can be escalated with additional treatments or adjuncts depending on the patient’s response and vital signs.